61. FRI0079 CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Takanashi, S.; Kaneko, Y.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. FRI0104 Long-Term Followup of Biologic Agents in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Kaneko, Y.; Kondo, H.; Ohta, M.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. FRI0107 Lumbar Bone Mineral Density in Patients with Early Rheumatoid Arthritis: Pre-Treatment Baseline Characteristics and Prospective 3-Year Cohort. (10th June 2014) Authors: Kaneko, Y.; Takeuchi, T.; Kuwana, M.; Kondo, H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. FRI0123 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS. (2nd June 2020) Authors: Genovese, M. C.; Smolen, J. S.; Takeuchi, T.; Burmester, G. R.; Deberdt, W.; Schlichting, D.; Song, H.; Mo, D.; Walls, C.; Winthrop, K. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. FRI0139 FILGOTINIB PROVIDED RAPID AND SUSTAINED RELIEF OF PAIN AND FATIGUE AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DMARDS: RESULTS FROM THE FINCH 2 STUDY. (2nd June 2020) Authors: Walker, D.; Takeuchi, T.; Bartok, B.; Rao, S.; Lee, I. H.; Besuyen, R.; Gottenberg, J. E.; Genovese, M. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. FRI0158 Safety of Biologic Agents in Elderly Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Murota, A.; Kaneko, Y.; Yamaoka, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. FRI0176 Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite dmard therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments. (23rd January 2014) Authors: Takeuchi, T.; Harigai, M.; Tanaka, Y.; Yamanaka, H.; Ishiguro, N.; Yamamoto, K.; Kanazawa, M.; Murakami, Y.; Yoshinari, T.; Baker, D.; Miyasaka, N.; Koike, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. FRI0177 52-week results of clinical, radiographic and pharmacokinetic assessments: Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy. (23rd January 2014) Authors: Tanaka, Y.; Harigai, M.; Takeuchi, T.; Yamanaka, H.; Ishiguro, N.; Yamamoto, K.; Kanazawa, M.; Murakami, Y.; Yoshinari, T.; Baker, D.; Miyasaka, N.; Koike, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. FRI0197 Golimumab monotherapy in patients with active rheumatoid arthritis despite dmard therapy: week 104 results of clinical, radiographic and safety assessments including evaluation of remission using the new acr/eular criteria. (23rd January 2014) Authors: Takeuchi, T.; Harigai, M.; Tanaka, Y.; Yamanaka, H.; Ishiguro, N.; Yamamoto, K.; Murakami, Y.; Yoshinari, T.; Baker, D.; Miyasaka, N.; Koike, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. FRI0200 Achievement of low disease activity (LDA) at 3 months predicts clinical remission (REM) at 1 year of infliximab (IFX) therapy in ra: post-hoc analysis of a randomized double-blind clinical study (rising study). (23rd January 2014) Authors: Takeuchi, T.; Yano, T.; Inui, T.; Yoshinari, T.; Miyasaka, N.; Abe, T.; Koike, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗